Editorial Board

86 Editors in 21 Countries/Region

USA (23)
Italy (17)
China (13)
Germany (5)
India (3)
Netherlands (3)
Portugal (3)
United Kingdom (3)
Canada (2)
Taiwan (2)
France (2)
Greece (1)
Israel (1)
Spain (1)
Turkey (1)
South Korea (1)
JP (1)
Belgium (1)
Singapore (1)
Australia (1)
Russia (1)

Executive Chief Editor

Ciro Isidoro


Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", Novara, Italy

Research Interests: lysosomal proteolysis, pathogenesis of diseases, cathepsin D, nanobioimaging, autophagy-lysosomal pathway in cancer and in neurodegeneration


Epigenetic control of autophagy in women’s tumors: role of non-coding RNAs

Special Issue:

Papers from the 3rd International Workshop No-Cancer 2018 ---Understanding Cancer Cell Biology to Improve Diagnosis and Therapy

Autophagy in Cancer and Therapy Resistance

Artificial Intelligence in Cancer Treatment and Prediction

Honorary Editors-in-Chief

Dai-Ming Fan

State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, Shaanxi, China

Research Interests: identification and application of gastric cancer associated antigens, multi-drug resistance of gastric cancer, immunogenetics and pathogenesis of gastric cancer

Yan Sun

Academician of Chinese Society of Engineering, Beijing, China

Research Interests: clinical oncology, non-small cell lung cancer, breast cancer, target therapy

Associate Editors

Wafik S. El-Deiry

Legorreta Cancer Center, Brown University, RI, USA

Research Interests: cell death, drug resistance in cancer

Special Issue:

Targeting Cell Death in Cancer Therapy

Speical Collection:

Cancer Cell Plasticity in Therapy Resistance

Gopal C. Kundu

KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, India

Research Interests: tumor biology, cancer stem cells, tumor-stroma interaction, angiogenesis, cancer therapeutics biomarker development, nanomedicine

Andrea M. Nicolini

Department of Internal Medicine, University of Pisa, Santa Chiara Hospital, Pisa, Italy

Research Interests: breast and gastrointestinal cancer and their metastases, tumour markers, post-operative follow-up, physiopathology, immunology and immunotherapy of cancer, thyroid tumours


Prognostic factors and efficacy of GDP-R therapy in refractory/relapsed diffuse large B-cell lymphomas not eligible for high-dose therapy

Godefridus J. Peters

Laboratory Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Research Interests: pharmacology of anticancer agents, antimetabolites, antifolates, platinum analogs, taxanes, anti-signalling agents, third generation targeted-agents


Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas

Special Issue:

Cancer Pharmacogenomics

John M. Pezzuto

College of Pharmacy and Health Sciences, Western New England University, Springfield, MA, USA

Research Interests: natural product drugs, drug discovery and characterization, cancer therapy and chemoprevention


Phytochemicals and cancer chemoprevention

Stephen J. Ralph

School of Medical Science, Griffith Health Institute, Griffith University, Southport, Queensland, Australia

Research Interests: melanoma vaccines, metastatic cancers, classification of mitocans, effects of laser irradiation on carcinoma

Domenico Ribatti

Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy

Research Interests: angiogenesis in hematological tumors, angiogenesis in hematological tumors, angiogenesis in bone tumors, role of mast cells in tumor angiogenesis, role of chemokines in angiogenesis, role of GM-CSF in angiogenesis, role of PDGF and sugars in angiogenesis, role of transferrin in angiogenesis

Special Issue:

Angiogenesis and Antiangiogenesis in Hematological Malignancies

Hans-Joachim Schmoll

University Hospital Halle (Saale), Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

Research Interests: colorectal cancer, gastrointestinal cancers, genitourinary cancers, germline cancers

Gautam Sethi

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Research Interests: transcription factors in cancer progression, cell signaling, chemoprevention, pharmaceuticals

Special Issue:

Nanoarchitectures and Natural-based Products in Cancer Drug Resistance: Time to Converge Biology and Engineering

Jan Baptist Vermorken

Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium

Research Interests: gynecologic oncology, head and neck oncology, breast and colon cancer


Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity

Special Issue:

Advanced Research of Drug Resistance in Head and Neck Cancer

Editorial Board Members

Consuelo Amantini

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy

Research Interests: transient receptor potential receptors, cancer cell line models, cellular pathways, autophagy, anti-cancer drug mechanisms

Zohreh Amoozgar

Department of Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Research Interests: hepatocellular carcinoma, cancer immunotherapy, breast cancer, glioblastoma, metastatic ovarian, cancer liver metastases

Milad Ashrafizadeh

Department of General Surgery and Institute of Precision Diagnosis and Treatment of Digestive System Tumors, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, China

Research Interests: cancer therapy, autophagy, apoptosis, cell death mechanisms, exosomes, epithelial-mesenchymal transition (EMT), biomaterials

Valeria Barresi

Università degli Studi di Verona, Verona, Italy

Research Interests: central nervous system, colorectal cancer, molecular, tumors

Jin-Xin Bei

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangdong, China

Research Interests: tumor heterogeneity, genetics and genomics, viral infection, tumor microenvironment, therapeutic resistance, precision medicine

Dominique A. Bonnet

Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London, UK

Research Interests: haematopoietic stem cells, blood cancer

Xiaofang Che

Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

Research Interests: translational research on precise diagnosis and treatment of gastrointestinal tumors based on hypoxia and immune microenvironment, anti-tumor peptide development, tumor metastasis and drug resistance mechanism, tumor peptide development, tumor metastasis and drug resistance mechanism research


Mesenchymal stem cell-derived extracellular vesicles for human diseases

Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy

Special Issue:

The Role of the Immune Micro-environment in Tumour Metastasis And Therapeutic Strategies

Jyh-Ping Chen

Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan, Taiwan

Research Interests: biomaterials, drug delivery, tissue engineering, nanomedicine

Wei Chen

Department of Physics, The University of Texas at Arlington, Arlington, TX, USA

Research Interests: nanotechnology, nanomedicine, cancer therapy, diabetes detection and prevention


Some synergetic therapy strategies for overcoming hypoxia for photodynamic therapy of cancer

Tuning Ag+ and Mn2+ doping in ZnS:Ag,Mn embedded polymers for flexible white light emitting films

Special Issue:

The Role of Nanotechnology in Cancer: Current Status and Challenges

Sheue-Yann Cheng

Gene Regulation Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Research Interests: thyroid hormone action, thyroid hormone receptors in health and disease, molecular genetics of thyroid cancer, mouse models

Chun Hei Antonio Cheung

Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, China

Research Interests: anti-cancer nanodrug development, cancer drug resistance mechanism, cancer cell autophagy


Introduction to this special issue - “Autophagy and Cancer: current biology and drug development”

Special Issue:

Autophagy and Cancer: current biology and drug development

Fausto Chiesa

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy

Research Interests: surgical oncology, thyroid cancer, oral precancerous lesions, oral cancer, squamous cell carcinoma of head and neck, larynx cancer

William C. Cho

Department of Clinical Oncology, Queen Elizabeth Hospital Hong Kong, Hong Kong, China

Research Interests: cancer biomarkers, surface-enhanced laser desorption and ionization(SELDI), microRNA


Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance

Special Issue:

The Emerging Role of Extracellular Vesicles in Cancer

Daxiang Cui

School of Sensing Science and Engineering, Shanghai Jiao Tong University, Shanghai, China

Research Interests: nano biomedicine and biosensor, cancer prewarning and early theranostics, intelligent detection instrument, molecular imaging and nanoprobes

Giuseppe Curigliano

Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico, University of Milano, Milan, Italy

Research Interests: early drug development, solid tumours, breast cancer


The use of liquid biopsy in early breast cancer: clinical evidence and future perspectives

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls

Antonio Facciorusso

Gastroenterology Unit, Department of Surgical and Medical Sciences, University of Foggia, Foggia, Italy

Research Interests: hepatocellular carcinoma, gastrointestinal endoscopy, endoscopic ultrasound, pancreatic cancer, colorectal cancer

Marco Falasca

Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia

Research Interests: signalling pathways, intracellular physiological and pathological processes, lysophospholipid lysophosphatidylinositol, phosphoinositide 3-kinase isoforms and phospholipase Cgamma-1, phosphoinositides, ABC transporters, G-protein coupled receptors, cancer progression and cell signalling

Special Issue:

Treatment of Pancreatic Cancer

Alfio Ferlito

Coordinator of the International Head and Neck Scientific Group, Padua, Italy

Research Interests: head and neck surgry, laryngology

Umberto Galderisi

Department of Molecular Biology, Second University of Naples, Naples, Italy

Research Interests: basic and applied researches on normal and cancer stem cells, analysis of senescence processes that affect stem cell properties, effect of low dose radiations on the biology of normal and cancer stem cells

Special Issue:

Basic and Applied Researches on Cancer Stem Cells

Antonio Giordano

Molecular Medicine and Center of Biotechnology and Sbarro Institute for Cancer Research, College of Science and Technology, Temple University, Philadelphia, PA, USA

Research Interests: cardiovascular disease, diabetes, cell cycle, genetics

Elisa Giovannetti

Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Netherlands;
Cancer Pharmacology Lab, Fondazione Pisana per La Scienza, Italy

Research Interests: molecular pharmacology, chemoresistance, targeting metastasis

Special Issue:

Targeted cancer therapy

Novel Targets for Therapy Resistant Pancreatic Carcinoma

Papers from the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group

New Therapies for Metastatic Non-Small Cell Lung Cancer

Speical Collection:

Cancer Cell Plasticity in Therapy Resistance

Lombardi Giuseppe

Department of Medical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy

Research Interests: brain tumor, glioblastoma


Gliomatosis cerebri: a monocentric real-life experience

Special Issue:

Primary and Secondary Brain Tumors

Alessandro Granito

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Research Interests: hepatocellular carcinoma, intrahepatic cholangiocarcinoma, cirrhosis, liver diseases


The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time

Arjan W. Griffioen

Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands

Research Interests: genetic profiling of tumor endothelium, cancer vaccines, combination therapy, personalized therapy

Gang Guo

Center for Gut Microbiome Research, Med-X Institute Centre, First Affiliated Hospital of Xi’an Jiaotong University, Xi'an, Shaanxi, China

Research Interests: gut microbe and digestive tract diseases

Elif Hindié

CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France

Research Interests: imaging in endocrinology, TEP imaging in oncology, internal vectored radiation therapy, theranostic applications

Dae Joong Kim

Department of Microbiology, Immunology and Cancer Biology, University of Virginia, VA, USA

Research Interests: cancer biology, tumor angiogenesis, tumor immunology, actin dynamics, vascular biology

Robert Arthur Kratzke

Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA

Research Interests: translational mesothelioma and lung cancer research


Covid19 and cancer care: the end of the beginning

Special Issue:

Lung Cancer Metastasis and Treatment under the Epidemic of COVID-19

Ajaikumar B. Kunnumakkara

Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, India

Research Interests: breast cancer, chemoprevention of neuroblastoma, pancreatic cancer

Gary Li

Biology and Translational Medicine, RayzeBio Inc., San Diego, CA, USA

Research Interests: targeted therapy, radiation therapy, drug discovery


Opportunities and challenges in developing tissue-agnostic anti-cancer drugs

Thomas Liehr

Jena University Hospital, Institute of Human Genetics, Friedrich Schiller University, Jena, Germany

Research Interests: inherited and acquired marker and derivative chromosomes, karyotype evolution, uniparental disomy, interphase architecture, probe set-developments


Cryptic NUP214-ABL1 fusion with complex karyotype, episomes and intra-tumor genetic heterogeneity in a T-cell lymphoblastic lymphoma

First molecular cytogenetic characterisation of tracheal squamous cell carcinoma cell line KLN 205

Brandon Lucke-Wold

Department of Neurosurgery, West Virginia University School of Medicine, Morgantown, WV, USA

Research Interests: metastasis, subarachnoid hemorrhage, neurosurgery, radiosurgery, meningioma


Advanced breast cancer metastasized in the brain: treatment standards and innovations

Special Issue:

Strategies in Medical and Surgical Treatment of Metastatic Cancer

Dario Marchetti

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, USA

Research Interests: circulating tumor cells, liquid biopsy, biomarkers, cancer metastasis, transcriptomics


Application of liquid biopsy for prognostic status of cancers and drug response

Special Issue:

The Biology and Therapeutic Utility of Circulating Tumor Cells (CTC)

A. C. Matin

Department of Microbiology and Immunology, Stanford University School of Medicine, California, USA

Research Interests: microbiology, immunology, therapy of cancer

Silvana Morello

Department of Pharmaceutical and Biomedical Sciences, University of Salerno, Via Ponte Don Melillo, Fisciano, Salerno, Italy

Research Interests: tumor microenvironment, metastatic melanoma, prognostic factor, tumor immunology, mitochondrial metabolism of tumor cells


Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target

Palanisamy Nallasamy

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, USA

Research Interests: pancreatic cancer, stem cells, tumor microenvironment, small molecule therapeutics, cardiovascular disease, experimental diabetes

Christos Papadimitriou

Oncology Unit, Second Department of Surgery, “Aretaieion” University Hospital, National and Kapodistrian University of Athens, Athens, Greece

Research Interests: bone marrow transplantation, gynecologic cancer, breast cancer, lung cancer, GI cancers


Neoadjuvant treatment of pancreatic ductal adenocarcinoma: present and future

Special Issue:

Breast Cancer Metastasis

Chandler H. Park

Norton Cancer Institute, Co-Director Genitourinary Oncology Clinical Trials, Advisory Dean/Clinical Professor at the University of Louisville, School of Medicine, Louisville, KY, USA

Research Interests: prostate cancer, bladder cancer, kidney cancer

Manash K. Paul

Department of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA

Research Interests: stem cell, organoid, lung cancer, disease modeling, drug discovery, exosome, nanotechnology

Leonel Pereira

Department of Life Sciences, University of Coimbra, MARE-Marine and Environmental Sciences Centre, Calçada Martim de Freitas, Coimbra, Portugal

Research Interests: phycology, marine biotechnology, biodiversity and taxonomy, bioinformatics and databases, environmental assessment, nutrition and thalassotherapy

Pier Paolo Piccaluga

Biobank of Research, IRCCS Azienda Opedaliera-Universitaria di Bologna; Institute of Hematology and Medical Oncology “L&A Seràgnoli” - Department of Medical and Surgical Sciences, University of Bologna, Italy

Research Interests: hematology, hematopathology, targeted therapy, molecular diagnostics, leukemia, lymphoma, drug resistance, cancer metabolism, genomics

Marc Poirot

French Institute of Health and Medical Research, Inserm Cancer Research Center of Toulouse, Toulouse, France

Research Interests: cholesterol metabolism, breast cancer, oncosterone, dendrogenin, cell differentiation and death, autophagy, drug design, medicinal chemistry, diet

Klaus Pors

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, West Yorkshire, UK

Research Interests: cytochrome, prostate cancer, drug discovery, target oriented synthesis, medicinal chemistry, diversity-oriented synthesis, small molecules, pharmacoepigenetics, molecular fluorescent probes


Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention

Current challenges and opportunities in treating hypoxic prostate tumors

Expression and regulation of aldehyde dehydrogenases in prostate cancer

Introduction of the special issue “How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?”

Special Issue:

How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?

Pravin Potdar

Department of Molecular Medicine & Biology, Jaslok Hospital & Research Centre, Mumbai, India

Research Interests: molecular diagnostics for breast cancer, lung cancer, pancreatic & prostate cancers, hematological malignancy, colon cancer, neurological and genetic disorders, cancer stem cells & therapies, early detection markers for breast, molecular targeted therapies of cancer


Role of circulating tumor cells in future diagnosis and therapy of cancer

Evaluation of anti-metastatic effect of chitosan nanoparticles on esophageal cancer-associated fibroblasts

Profiling of circulating tumor cells in liquid biopsies from metastatic cancer patients

Circulating tumor cells: hope to diagnose and treat metastatic cancer

Special issue on “Immunotherapy of cancer: future possible therapy for metastatic cancer”

Special Issue:

Immunotherapy Of Cancer: Future Possible Therapy For Metastatic Cancer

Giuliano Ramadori

Professor of Medicine, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany

Research Interests: gene expression, liver cells (hepatocytes, kupffer cells, endothelial cells, stellate cells), pathogenesis, inflammation, cancer development, animal models of liver cancer diagnostic procedures and therapy, COVID-19 diagnostic and treatment, mechanisms of acute-phaseresponse, gastrointestinal cancer diagnostic and endoscopic therapy, systemic cancer therapy, tumor microenviroment analysis, liver diseases diagnostic, therapy, iron metabolism, radiation biology

Boris Reva

Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Interests: molecular diagnostics, clinical subtypes and precise medicine of cancer, cancer genomics and immune therapy

H.P. Vasantha Rupasinghe

Department of Plant, Food, and Environmental Sciences, Faculty of Agriculture, Dalhousie University, Nova Scotia, Canada

Research Interests: medicinal biochemistry of phytochemicals, disease-fighting properties of plant flavonoids and their analogues, polyphenol micronutrients of cool climate fruits and disease prevention

Jesús San-Miguel

Clinica Universitaria de Navarra, Pamplona, Spain

Research Interests: myeloma cell biology, minimal residual disease, proteasome inhibitors, immunomodulatory drugs, histone deacetylases

Lúcio Lara Santos

Department of Surgical Oncology, Portuguese Oncology Institute-Porto (IPO-Porto), Porto, Portugal

Research Interests: surgical oncology and carcinogenesis, experimental pathology and oncology, gastrointestinal, breast cancer, cancers related to infections

Marcus Schmidt

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, University Medical Center Mainz, Langenbeckstr, Mainz, Germany

Research Interests: prognostic and predictive factors in breast cancer, immunotherapy in breast cancer, endocrine therapy in breast cancer


Endocrine therapy in metastatic breast cancer-more than just CDK4/6 inhibitors

Hildegard M. Schuller

Experimental Oncology Laboratory, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA

Research Interests: comparative pathology, lung cancer, G protein-coupled receptors, pancreatic cancer, stem cell

Consolato Sergi

Anatomic Pathology Division, Pediatric Pathologist, Children’s Hospital of Eastern Ontario (CHEO) Full Professor of Pathology & Pediatrics, University, Canada

Research Interests: pediatric oncology, pediatric developmental pathology

Special Issue:

Etiology and Pathogenesis of Hepatocellular and Cholangiocellular Carcinoma

Rakesh Srivastava

Louisiana State University Health-New Orleans, School of Medicine, Stanley S. Scott Cancer Center, New Orleans, Louisiana, USA

Research Interests: cancer biology, cell signal, molecular mechanisms, stem cells, human diseases

Hailin Tang

Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China

Research Interests: cancer, metastasis, proliferation, non-coding RNA

Special Issue:

Role of Non-Coding RNA in Cancer Drug Resistance

Giovanna Tosato

Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Research Interests: cancer, endothelial cells, vascular biology, hematopoietic stem cell niches


Bone marrow niches in myelodysplastic syndromes

Giovanni Tuccari

Department of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy

Research Interests: triple negative breast carcinomas, prognostic markers, HER2 heterogeneity, human pathology


Uterine large cell neuroendocrine carcinoma with unusual colonic metastasis

Changes in human epidermal growth factor receptor 2 status between primary breast/gastric carcinomas and synchronous metastatic lymph nodes: how can we explain them?

Special Issue:

Targeted Therapies and Predictive Biomarkers for Breast Cancer

Yogesh Vashist

Department of Surgery, Asklepios Harzklinik Goslar, Goslar, Germany

Research Interests: pancreatic cancer, microRNAs, long noncoding RNA

Paula Videira

Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal

Research Interests: cancer-associated glycans, dendritic cell-based vaccines, novel biomarkers in cancer

Valeria Visconte

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Research Interests: myeloid malignancies, myelodysplastic syndromes, myeloid malignancies, acute myeloid leukemia (AML), paroxysmal nocturnal hemoglobinuria (PNH)

Special Issue:

Therapy-related Myeloid Neoplasms

Israel Vlodavsky

Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Research Interests: cancer metastasis, heparanase, extracellular matrix, tumor microenvironment in cancer progression

Xianwen Wang

School of Biomedical Engineering, Anhui Medical University, Hefei, China

Research Interests: cancer therapy, nanomedicine, biomaterials, drug delivery, nanotechnology

Yaoqi Alan Wang

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Research Interests: cancer biology, glioblastoma, neoplasms, tumors, chemical compounds, glioma, stem cells, pancreatic neoplasms, prostatic neoplasms, adenocarcinoma

Murali Yallapu

Department of Immunology and Microbiology, Institute for Cancer Immunotherapy, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA

Research Interests: nanotechnology, drug delivery, cancer, biomaterials, miRNA

Qifeng Yang

Qilu Hospital, Shandong University, Jinan, Shandong, China

Research Interests: breast cancer, chemoresistance, metastasis, biomarker

Shun-Fa Yang

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

Research Interests: pharmacology, oral cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in oral cancer

Haijun Yu

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

Research Interests: targeted drug delivery system, immune regulation and vaccines

Vladimir Zaichick

Medical Radiological Research Center, Obninsk, Russia

Research Interests: in vivo and in vitro nuclear analytical methods of chemical element contents measurement in tissues and fluids of human body, age- and gender-dependence of chemical element contents in tissues and fluids, levels of chemical element contents in tissues and fluids as tumour’s markers


Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer

Levels of chemical element contents in thyroid as potential biomarkers for cancer diagnosis (a preliminary study)

Yudong Zhang

School of Computing and Mathematical Sciences, University of Leicester, Leicester, United Kingdom

Research Interests: deep learning, cancer detection, prognosis, prediction, treatment

Special Issue:

Artificial Intelligence and Disease Prediction and Diagnosis

Hongyun Zhao

Collaborative Innovation Center for Cancer Medicine, Sun Yat- Sen University Cancer Center, Guangzhou, Guangdong, China

Research Interests: lung cancer, nasopharyngeal cancer, chemotherapy, targeted therapy, immunotherapy, clinical trials of anti-tumor new drugs

Special Issue:

New Therapies for Metastatic Non-Small Cell Lung Cancer

Founder and Editor-in-Chief Emeritus

Lucio Miele

Department of Genetics, School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA

Research Interests: cancer stem cell-regulatory genes, GWAS, transcriptome, cancer-associated genes, genomic biomarkers, cancer health disparities


Introduction to Volume 1 Issue 2 of Journal of Cancer Metastasis and Treatment

Neuroendocrine tumors: current therapies, notch signaling, and cancer stem cells

Special Issue:

Artificial Intelligence in Cancer Treatment and Prediction

All members of the Editorial Board have identified their affiliated institutions or organizations, along with the corresponding country or geographic region. OAE Publishing Inc. remains neutral with regard to any jurisdictional claims.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)


All published articles are preserved here permanently:



All published articles are preserved here permanently: